Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society
Andrew M.D. Wolf,Elizabeth T. H. Fontham,Timothy R. Church,Christopher R. Flowers,Carmen Guerra,Samuel J. LaMonte,Ruth Etzioni,Matthew T. McKenna,Kevin C. Oeffinger,Ya Chen Tina Shih,Louise C. Walter,Kimberly S. Andrews,Otis W. Brawley,Durado Brooks,Stacey A. Fedewa,Deana Manassaram-Baptiste,Rebecca L. Siegel,Richard C. Wender,Robert A. Smith +18 more
Reads0
Chats0
TLDR
This guideline update used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence.Abstract:
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC. Results from modeling analyses identified efficient and model-recommendable strategies that started screening at age 45 years. The ACS Guideline Development Group applied the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria in developing and rating the recommendations. The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability. As a part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy. The recommendation to begin screening at age 45 years is a qualified recommendation. The recommendation for regular screening in adults aged 50 years and older is a strong recommendation. The ACS recommends (qualified recommendations) that: 1) average-risk adults in good health with a life expectancy of more than 10 years continue CRC screening through the age of 75 years; 2) clinicians individualize CRC screening decisions for individuals aged 76 through 85 years based on patient preferences, life expectancy, health status, and prior screening history; and 3) clinicians discourage individuals older than 85 years from continuing CRC screening. The options for CRC screening are: fecal immunochemical test annually; high-sensitivity, guaiac-based fecal occult blood test annually; multitarget stool DNA test every 3 years; colonoscopy every 10 years; computed tomography colonography every 5 years; and flexible sigmoidoscopy every 5 years. CA Cancer J Clin 2018;68:250-281. © 2018 American Cancer Society.read more
Citations
More filters
Journal ArticleDOI
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung,Jacques Ferlay,Rebecca L. Siegel,Mathieu Laversanne,Isabelle Soerjomataram,Ahmedin Jemal,Freddie Bray +6 more
TL;DR: The GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer (IARC) as mentioned in this paper show that female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung cancer, colorectal (11 4.4%), liver (8.3%), stomach (7.7%) and female breast (6.9%), and cervical cancer (5.6%) cancers.
Journal ArticleDOI
Colorectal cancer statistics, 2020.
Rebecca L. Siegel,Kimberly D. Miller,Ann Goding Sauer,Stacey A. Fedewa,Lynn F. Butterly,Lynn F. Butterly,Joseph C. Anderson,Joseph C. Anderson,Andrea Cercek,Robert A. Smith,Ahmedin Jemal +10 more
TL;DR: Progress against CRC can be accelerated by increasing access to guideline‐recommended screening and high‐quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle‐aged adults.
Journal ArticleDOI
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo,David C. Grossman,Susan J. Curry,Karina W. Davidson,John W. Epling,Francisco A.R. Garcia,Matthew W. Gillman,Diane M. Harper,Alex R. Kemper,Alex H. Krist,Ann E. Kurth,C. Seth Landefeld,Carol M. Mangione,Douglas K Owens,Douglas K Owens,William R. Phillips,Maureen G. Phipps,Michael Pignone,Albert L. Siu,Albert L. Siu +19 more
TL;DR: It is concluded with high certainty that screening for colorectal cancer in average-risk, asymptomatic adults aged 50 to 75 years is of substantial net benefit.
Journal ArticleDOI
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
NaNa Keum,Edward Giovannucci +1 more
TL;DR: With increasing incidence of CRC at younger ages, there is an urgent need to better identify high-risk individuals younger than 50 years, the age when screening typically starts, and aspirin probably confers chemopreventive benefit against CRC.
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Kathleen A. Cronin,Andrew J. Lake,Susan Scott,Recinda L. Sherman,Anne-Michelle Noone,Nadia Howlader,S. Jane Henley,Robert N. Anderson,Albert U. Firth,Jiemin Ma,Betsy A. Kohler,Ahmedin Jemal +11 more
TL;DR: The American Cancer Society, the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate to provide annual updates on cancer occurrence and trends in the United States.
References
More filters
Journal ArticleDOI
Colorectal Cancer Incidence Patterns in the United States, 1974-2013.
Rebecca L. Siegel,Stacey A. Fedewa,William F. Anderson,Kimberly D. Miller,Jiemin Ma,Philip S. Rosenberg,Ahmedin Jemal +6 more
TL;DR: Age-specific CRC risk has escalated back to the level of those born circa 1890 for contemporary birth cohorts, underscoring the need for increased awareness among clinicians and the general public, as well as etiologic research to elucidate causes for the trend.
Journal ArticleDOI
Accuracy of CT Colonography for Detection of Large Adenomas and Cancers
C. Daniel Johnson,Mei Hsiu Chen,Alicia Y. Toledano,Jay P. Heiken,Abraham H. Dachman,Mark D. Kuo,Christine O. Menias,Betina Siewert,Jugesh I. Cheema,Richard G. Obregon,Jeff L. Fidler,Peter Zimmerman,Karen M. Horton,Kevin J. Coakley,Revathy B. Iyer,Amy K. Hara,Robert A. Halvorsen,Giovanna Casola,Judy Yee,Benjamin A. Herman,Lawrence J. Burgart,Paul J. Limburg +21 more
TL;DR: In this study of asymptomatic adults, CT colonographic screening identified 90% of subjects with adenomas or cancers measuring 10 mm or more in diameter, augmenting published data on the role of CT colonography in screening patients with an average risk of colorectal cancer.
Journal ArticleDOI
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Lois B. Travis,Sophie D. Fosså,Sara J. Schonfeld,Mary L. McMaster,Charles F. Lynch,Hans H. Storm,Per Hall,Eric J. Holowaty,Aage Andersen,Eero Pukkala,Martin Andersson,Magnus Kaijser,Mary Gospodarowicz,Timo Joensuu,Randi J. Cohen,John D. Boice,Graça M. Dores,Ethel S. Gilbert +17 more
TL;DR: Testicular cancer survivors are at statistically significantly increased risk of solid tumors for at least 35 years after treatment, and young patients may experience high levels of risk as they reach older ages.
Journal ArticleDOI
Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010
Christina E. Bailey,Chung Yuan Hu,Y. Nancy You,Brian K. Bednarski,Miguel A. Rodriguez-Bigas,John M. Skibber,Scott B. Cantor,George J. Chang +7 more
TL;DR: There has been a significant increase in the incidence of CRC diagnosed in young adults, with a decline in older patients, and further studies are needed to determine the cause for these trends and identify potential preventive and early detection strategies.
Journal ArticleDOI
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
TL;DR: A guideline from the U.S. Preventive Services Task Force as mentioned in this paper addresses aspirin use for the prevention of cardiovascular disease and colorectal cancer. The recommendations apply to adults aged 40 years and older.
Related Papers (5)
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo,David C. Grossman,Susan J. Curry,Karina W. Davidson,John W. Epling,Francisco A.R. Garcia,Matthew W. Gillman,Diane M. Harper,Alex R. Kemper,Alex H. Krist,Ann E. Kurth,C. Seth Landefeld,Carol M. Mangione,Douglas K Owens,Douglas K Owens,William R. Phillips,Maureen G. Phipps,Michael Pignone,Albert L. Siu,Albert L. Siu +19 more